Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer

被引:7
|
作者
Al-Obeidi, Ebaa [1 ]
Riess, Jonathan W. [1 ]
Malapelle, Umberto [2 ]
Rolfo, Christian [3 ]
Gandara, David R. [1 ]
机构
[1] Univ Calif Davis, Div Hematol Oncol, 4501 10 St,Suite 3016, Sacramento, CA 95817 USA
[2] Univ Naples Federico II, Dept Publ Hlth, Via Sergio Pansini 5, I-80131 Naples, Italy
[3] Icahn Sch Med Mt Sinai, Ctr Thorac Oncol, Tisch Canc Inst, One Gustave Levy Pl,Box 1079, New York, NY 10029 USA
关键词
Liquid biopsy; Circulating tumor DNA (ctDNA); Next-generation sequencing (NGS); Minimal residual disease (MRD); Tumor mutational burden (TMB); Non-small cell lung cancer (NSCLC); CIRCULATING TUMOR DNA; RESIDUAL DISEASE; CLINICAL UTILITY; RESISTANCE; LANDSCAPE; BLOCKADE;
D O I
10.1016/j.hoc.2023.02.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [31] Precision nanomedicine to treat non-small cell lung cancer
    Dessai, Akanksha
    Nayak, Usha Yogendra
    Nayak, Yogendra
    LIFE SCIENCES, 2024, 346
  • [32] Non-small cell lung cancer in the era of precision medicine
    Rivas, Solange
    Armisen, Ricardo
    REVISTA MEDICA CLINICA LAS CONDES, 2022, 33 (01): : 25 - 35
  • [33] Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era
    Palmieri, Maria
    Frullanti, Elisa
    MEDICAL SCIENCES, 2023, 11 (01)
  • [34] Comparison Between Liquid Biopsy and Conventional Tissue Biopsy in EGFR Genotyping of Non-Small Cell Lung Cancer
    Lee, S. H.
    Kim, E. Y.
    Kim, A.
    Kim, T.
    Chang, Y. S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S501 - S501
  • [35] An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer
    Mayo-de-Las-Casas, Clara
    Garzon Ibanez, Monica
    Jordana-Ariza, Nuria
    Garcia-Pelaez, Beatriz
    Balada-Bel, Ariadna
    Villatoro, Sergio
    Malapelle, Umberto
    Karachaliou, Niki
    Troncone, Giancarlo
    Rosell, Rafael
    Angel Molina-Vila, Miguel
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (01) : 35 - 45
  • [36] Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
    Nagasaka, Misako
    Uddin, Mohammed Hafiz
    Al-Hallak, Mohammed Najeeb
    Rahman, Sarah
    Balasubramanian, Suresh
    Sukari, Ammar
    Azmi, Asfar S.
    MOLECULAR CANCER, 2021, 20 (01)
  • [37] The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
    Akhoundova, D.
    Mosquera Martinez, J.
    Musmann, L. E.
    Britschgi, C.
    Rutsche, C.
    Rechsteiner, M.
    Nadal, E.
    Garcia Campelo, M. R.
    Curioni-Fontecedro, A.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 19
  • [38] Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
    Perez-Callejo, David
    Romero, Atocha
    Provencio, Mariano
    Torrente, Maria
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 455 - 465
  • [39] The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Sama, Srikar
    Le, Thuy
    Ullah, Asad
    Elhelf, Islam A.
    Kavuri, Sravan K.
    Karim, Nagla Abdel
    CLINICS AND PRACTICE, 2022, 12 (03) : 419 - 424
  • [40] Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
    Misako Nagasaka
    Mohammed Hafiz Uddin
    Mohammed Najeeb Al-Hallak
    Sarah Rahman
    Suresh Balasubramanian
    Ammar Sukari
    Asfar S. Azmi
    Molecular Cancer, 20